Akebia Therapeutics, Inc.

$1.44
+0.01 (+0.87%)

Volume:

965.338K ($1.39M)

Market Capitalization:

$386.42M

Akebia Therapeutics Price Chart

Akebia Therapeutics Price Chart4:20 AM5:40 AM7:00 AM8:20 AM9:40 AM11:00 AM12:20 PM1.451.441.441.431.431.421.42

Akebia Therapeutics Volume Chart

Akebia Therapeutics Volume Chart4:20 AM5:40 AM7:00 AM8:20 AM9:40 AM11:00 AM12:20 PM424.29K363.68K303.06K242.45K181.84K121.23K60.61K

Akebia Therapeutics Market Segments

Regular Trading Hours

+0.02(+1.58%)
Open$1.42
Close$1.44
Low$1.42
Low Change-0.01 (-0.35%)
High$1.45
High Change+0.03 (+2.11%)
Range$0.04
Volume965.338K
Dollar Volume$1.39M

Premarket

*No Trades in Segment

After Hours Yesterday

-0.01(-0.70%)
Open$1.42
Close$1.41
Low$1.40
Low Change-0.02 (-1.41%)
High$1.43
High Change+0.01 (+0.70%)
Range$0.03
Volume12.638K
Dollar Volume$17.82K

Regular Trading Hours Yesterday

+0.02(+1.42%)
Open$1.41
Close$1.43
Low$1.39
Low Change-0.02 (-1.42%)
High$1.44
High Change+0.03 (+2.13%)
Range$0.05
Volume1.6M
Dollar Volume$2.29M

Premarket Yesterday

-0.03(-2.07%)
Open$1.45
Close$1.42
Low$1.41
Low Change-0.04 (-2.76%)
High$1.45
High Change+0.00 (+0.00%)
Range$0.04
Volume3.959K
Dollar Volume$5.62K

Akebia Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.47
10 Day Moving Average (SMA10)$1.42
20 Day Moving Average (SMA20)$1.33
50 Day Moving Average (SMA50)$1.37
100 Day Moving Average (SMA100)$1.58
200 Day Moving Average (SMA200)$2.45

Akebia Therapeutics Statistics

Average Volume (30 Days)3.55M
P/E Ratio (Current)-72.00
EPS (Current)-$0.02
Dividend Yield0.00%
Free Cash Flow$67.70M
Cash Ratio1.13
Current Ratio1.55
Quick Ratio1.46
Debt to Equity1.48
Enterprise Value$249.15M
EV to EBITDA10.06
EV to Sales1.05
Price to Book11.83
Price to Cash Flow5.67
Price to Free Cash Flow5.70
Price to Sales1.63
Return on Assets-0.01%
Return on Equity-0.16%

Akebia Therapeutics Stock Splits

There have been no stock splits for Akebia Therapeutics (AKBA).

Akebia Therapeutics Dividends

There have been no dividends for Akebia Therapeutics (AKBA).